SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Woodward, Inc. – ‘10-K’ for 9/30/22 – ‘R29’

On:  Friday, 11/18/22, at 4:31pm ET   ·   For:  9/30/22   ·   Accession #:  1564590-22-38033   ·   File #:  1-39265

Previous ‘10-K’:  ‘10-K’ on 11/19/21 for 9/30/21   ·   Next & Latest:  ‘10-K’ on 11/17/23 for 9/30/23   ·   24 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/18/22  Woodward, Inc.                    10-K        9/30/22  171:45M                                    ActiveDisclosure/FA

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   8.49M 
 2: EX-3.2      EX-3.2 Updated Bylaws                               HTML    274K 
 3: EX-10       Ex-10.31                                            HTML   4.96M 
 5: EX-10       Ex-10.34                                            HTML    241K 
 4: EX-10.32    EX-10.32 Ross                                       HTML    490K 
 6: EX-21.1     Subsidiaries List                                   HTML     54K 
 7: EX-23.1     Consent of Expert or Counsel                        HTML     46K 
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     56K 
 9: EX-31.2     Certification -- §302 - SOA'02                      HTML     56K 
10: EX-32.1     Certification -- §906 - SOA'02                      HTML     49K 
16: R1          Document and Entity Information                     HTML    116K 
17: R2          Consolidated Statements of Earnings                 HTML    121K 
18: R3          Consolidated Statements of Comprehensive Earnings   HTML    111K 
19: R4          Consolidated Balance Sheets                         HTML    163K 
20: R5          Consolidated Balance Sheets (Parenthetical)         HTML     72K 
21: R6          Consolidated Statements of Cash Flows               HTML    144K 
22: R7          Consolidated Statements of Stockholders' Equity     HTML    143K 
23: R8          Consolidated Statements of Stockholders' Equity     HTML     49K 
                (Parenthetical)                                                  
24: R9          Operations and Summary of Significant Accounting    HTML    156K 
                Policies                                                         
25: R10         New Accounting Standards                            HTML     63K 
26: R11         Revenue                                             HTML    450K 
27: R12         Earnings Per Share                                  HTML    129K 
28: R13         Leases                                              HTML    253K 
29: R14         Joint Venture                                       HTML    110K 
30: R15         Financial Instruments and Fair Value Measurements   HTML    232K 
31: R16         Derivative Instruments and Hedging Activities       HTML    150K 
32: R17         Supplemental Statement of Cash Flows Information    HTML     92K 
33: R18         Acquisitions and Divestitures                       HTML    130K 
34: R19         Inventories                                         HTML     76K 
35: R20         Property, Plant, and Equipment                      HTML    102K 
36: R21         Goodwill                                            HTML    103K 
37: R22         Intangible Assets, Net                              HTML    334K 
38: R23         Credit Facilities, Short-term Borrowings and        HTML    176K 
                Long-term Debt                                                   
39: R24         Accrued Liabilities                                 HTML    250K 
40: R25         Other Liabilities                                   HTML     83K 
41: R26         Other (Income) Expense, Net                         HTML     90K 
42: R27         Income Taxes                                        HTML    284K 
43: R28         Retirement Benefits                                 HTML   1.64M 
44: R29         Stockholders' Equity                                HTML    241K 
45: R30         Commitments and Contingencies                       HTML     68K 
46: R31         Segment Information                                 HTML    292K 
47: R32         Operations and Summary of Significant Accounting    HTML    225K 
                Policies (Policies)                                              
48: R33         Operations and Summary of Significant Accounting    HTML    101K 
                Policies (Tables)                                                
49: R34         Revenue (Tables)                                    HTML    451K 
50: R35         Earnings Per Share (Tables)                         HTML    133K 
51: R36         Leases (Tables)                                     HTML    257K 
52: R37         Joint Venture (Tables)                              HTML    110K 
53: R38         Financial Instruments and Fair Value Measurements   HTML    227K 
                (Tables)                                                         
54: R39         Derivative Instruments and Hedging Activities       HTML    134K 
                (Tables)                                                         
55: R40         Supplemental Statement of Cash Flows Information    HTML     91K 
                (Tables)                                                         
56: R41         Acquisitions and Divestitures (Tables)              HTML    132K 
57: R42         Inventories (Tables)                                HTML     77K 
58: R43         Property, Plant, and Equipment (Tables)             HTML    101K 
59: R44         Goodwill (Tables)                                   HTML    102K 
60: R45         Intangible Assets, Net (Tables)                     HTML    334K 
61: R46         Credit Facilities, Short-term Borrowings and        HTML    162K 
                Long-term Debt (Tables)                                          
62: R47         Accrued Liabilities (Tables)                        HTML    253K 
63: R48         Other Liabilities (Tables)                          HTML     82K 
64: R49         Other (Income) Expense, Net (Tables)                HTML     89K 
65: R50         Income Taxes (Tables)                               HTML    285K 
66: R51         Retirement Benefits (Tables)                        HTML   1.65M 
67: R52         Stockholders' Equity (Tables)                       HTML    248K 
68: R53         Commitments and Contingencies (Tables)              HTML     63K 
69: R54         Segment Information (Tables)                        HTML    292K 
70: R55         Operations and Summary of Significant Accounting    HTML     53K 
                Policies (Narrative) (Details)                                   
71: R56         Operations and Summary of Significant Accounting    HTML     77K 
                Policies (Schedule of Property, Plant and                        
                Equipment Useful Lives) (Details)                                
72: R57         Operations and Summary of Significant Accounting    HTML     62K 
                Policies (Schedule of Finite-Lived Intangible                    
                Assets Useful Lives) (Details)                                   
73: R58         New Accounting Standards (Narrative) (Details)      HTML     51K 
74: R59         Revenue - Revenue Derived from Product Sales        HTML     58K 
                (Details)                                                        
75: R60         Revenue (Schedule of Revenue Recognition Time)      HTML     66K 
                (Details)                                                        
76: R61         Revenue (Summary of Amounts Recognized Related to   HTML     51K 
                Changes in Estimated Total Lifetime Sales for                    
                Material Rights and Costs to Fulfill Contracts                   
                With Customers) (Details)                                        
77: R62         Revenue (Summary of Amounts Recognized Related to   HTML     51K 
                Amortization of Costs to Fulfill Contracts and                   
                Contract Liabilities Not Related to Changes in                   
                Estimate) (Details)                                              
78: R63         Revenue (Narrative) (Details)                       HTML     62K 
79: R64         Revenue (Schedule of Accounts Receivable)           HTML     65K 
                (Details)                                                        
80: R65         Revenue (Schedule of Uncollectible Amounts And      HTML     60K 
                Change in Expected Allowance for Credit Losses for               
                Trade Accounts Receivable and Unbilled                           
                Receivables) (Details)                                           
81: R66         Revenue (Schedule of Contract Liability) (Details)  HTML     62K 
82: R67         Revenue (Narrative - Performance Obligations)       HTML     49K 
                (Details)                                                        
83: R68         Revenue (Narrative - Performance Obligations)       HTML     59K 
                (Details1)                                                       
84: R69         Revenue (Schedule of Disaggregation of Revenue)     HTML    104K 
                (Details)                                                        
85: R70         Earnings Per Share (Reconciliation of Net Earnings  HTML     84K 
                to Net Earnings Per Share Basic and Diluted)                     
                (Details)                                                        
86: R71         Earnings Per Share (Anti-dilutive Stock Options     HTML     53K 
                Excluded from Computation of Earnings Per Share)                 
                (Details)                                                        
87: R72         Earnings Per Share (Schedule of Treasury Stock      HTML     49K 
                Shares Held for Deferred Compensation Included in                
                Basic and Diluted Shares Outstanding) (Details)                  
88: R73         Leases (Lease-Related Assets and Liabilities)       HTML     79K 
                (Details)                                                        
89: R74         Leases (Narrative) (Details)                        HTML     56K 
90: R75         Leases (Supplemental Lease-Related Information)     HTML     56K 
                (Details)                                                        
91: R76         Leases (Lease-Related Expenses) (Details)           HTML     64K 
92: R77         Leases (Lease-Related Supplemental Cash Flow        HTML     59K 
                Information) (Details)                                           
93: R78         Leases (Maturities of Lease Liabilities) (Details)  HTML     87K 
94: R79         Leases (Property, Plant and Equipment Leased to     HTML     52K 
                Others through Embedded Leasing Arrangements)                    
                (Details)                                                        
95: R80         Joint Venture (Unamortized Deferred Revenue from    HTML     53K 
                JV) (Details)                                                    
96: R81         Joint Venture (Narrative) (Details)                 HTML     72K 
97: R82         Joint Venture (Other Income Related JV) (Details)   HTML     53K 
98: R83         Joint Venture (Cash Distribution from JV)           HTML     52K 
                (Details)                                                        
99: R84         Joint Venture (Net Sales to the JV) (Details)       HTML     54K 
100: R85         Joint Venture (Accounts Receivable, Accounts        HTML     57K  
                Payable, and Other Assets Related to JV) (Details)               
101: R86         Financial Instruments and Fair Value Measurements   HTML     76K  
                (Financial Assets and Liabilities that are                       
                Measured at Fair Value on a Recurring Basis)                     
                (Details)                                                        
102: R87         Financial Instruments and Fair Value Measurements   HTML     66K  
                (Narrative) (Details)                                            
103: R88         Financial Instruments and Fair Value Measurements   HTML     67K  
                (Estimated Fair Values of Financial Instruments)                 
                (Details)                                                        
104: R89         Derivative Instruments and Hedging Activities       HTML    118K  
                (Narrative) (Details)                                            
105: R90         Derivative Instruments and Hedging Activities       HTML     75K  
                (Impact of Derivative Instruments on Earnings)                   
                (Details)                                                        
106: R91         Supplemental Statement of Cash Flows Information    HTML     64K  
                (Schedule of Supplemental Statement of Cash Flows                
                Information) (Details)                                           
107: R92         Acquisitions and Divestitures (Narrative)           HTML     83K  
                (Details)                                                        
108: R93         Acquisitions and Divestitures (Schedule of          HTML     57K  
                Purchase Price Consideration) (Details)                          
109: R94         Acquisitions and Divestitures (Schedule of Assets   HTML     80K  
                Acquired and Liabilities Assumed) (Details)                      
110: R95         Acquisitions and Divestitures (Schedule of          HTML     60K  
                Finite-Lived Intangible Assets Acquired) (Details)               
111: R96         Acquisitions and Divestitures (Carrying Value of    HTML     76K  
                the Assets and Liabilities Sold) (Details)                       
112: R97         Inventories (Schedule of Inventories) (Details)     HTML     63K  
113: R98         Property, Plant, and Equipment (Schedule of         HTML     73K  
                Property Plant and Equipment, Net) (Details)                     
114: R99         Property, Plant, and Equipment (Narrative)          HTML     63K  
                (Details)                                                        
115: R100        Property, Plant, and Equipment (Schedule of         HTML     49K  
                Depreciation Expense) (Details)                                  
116: R101        Goodwill (Schedule of Goodwill) (Details)           HTML     60K  
117: R102        Goodwill (Narrative) (Details)                      HTML     71K  
118: R103        Intangible Assets, Net (Schedule of Finite-Lived    HTML     90K  
                and Indefinite-Lived Intangible Assets by Major                  
                Class) (Details)                                                 
119: R104        Intangible Assets, Net (Narrative) (Details)        HTML     60K  
120: R105        Intangible Assets, Net (Schedule of Finite-Lived    HTML     49K  
                Intangible Assets Amortization Expense) (Details)                
121: R106        Intangible Assets, Net (Schedule of Finite-Lived    HTML     62K  
                Intangible Assets, Future Amortization Expense)                  
                (Details)                                                        
122: R107        Credit Facilities, Short-term Borrowings and        HTML     64K  
                Long-term Debt (Short-term Borrowings and                        
                Availability Under Various Short-term Credit                     
                Facilities) (Details)                                            
123: R108        Credit Facilities, Short-term Borrowings and        HTML    158K  
                Long-term Debt (Narrative) (Details)                             
124: R109        Credit Facilities, Short-term Borrowings and        HTML     98K  
                Long-term Debt (Schedule of Long-term Debt)                      
                (Details)                                                        
125: R110        Credit Facilities, Short-term Borrowings and        HTML     64K  
                Long-term Debt (Schedule of Future Principal                     
                Payments of Long-term Debt) (Details)                            
126: R111        Accrued Liabilities (Accrued Liabilities)           HTML     71K  
                (Details)                                                        
127: R112        Accrued Liabilities (Accrued Liabilities)           HTML     49K  
                (Parenthetical) (Details)                                        
128: R113        Accrued Liabilities (Changes in Accrued Product     HTML     55K  
                Warranties and Related Liabilities) (Details)                    
129: R114        Accrued Liabilities (Narrative) (Details)           HTML     65K  
130: R115        Accrued Liabilities (Changes in Restructuring       HTML     78K  
                Reserve Activity) (Details)                                      
131: R116        Other Liabilities (Schedule of Other Liabilities)   HTML     69K  
                (Details)                                                        
132: R117        Other (Income) Expense, Net (Schedule of Other      HTML     63K  
                (Income) Expense, Net) (Details)                                 
133: R118        Other (Income) Expense, Net (Schedule of Other      HTML     52K  
                (Income) Expense, Net) (Parenthetical) (Details)                 
134: R119        Income Taxes (Components of Income Tax Expense      HTML     69K  
                (Benefit)) (Details)                                             
135: R120        Income Taxes (Earnings Before Income Taxes by       HTML     57K  
                Geographical Area) (Details)                                     
136: R121        Income Taxes (Schedule of Deferred Tax Assets and   HTML     89K  
                Liabilities) (Details)                                           
137: R122        Income Taxes (Narrative) (Details)                  HTML     73K  
138: R123        Income Taxes (Reconciliation of U.S Statutory Rate  HTML     70K  
                to Effective Tax Rate) (Details)                                 
139: R124        Income Taxes (Reconciliation of the Beginning and   HTML     58K  
                Ending Amounts of Gross Unrecognized Tax Benefits)               
                (Details)                                                        
140: R125        Retirement Benefits (Narrative) (Details)           HTML    142K  
141: R126        Retirement Benefits (Schedule of Amount of Expense  HTML     49K  
                Associated with Defined Contribution Plans)                      
                (Details)                                                        
142: R127        Retirement Benefits (Schedule of Assumptions Used)  HTML     83K  
                (Details)                                                        
143: R128        Retirement Benefits (Schedule of Net Periodic       HTML     97K  
                Benefit Costs) (Details)                                         
144: R129        Retirement Benefits (Schedule of Changes in         HTML    112K  
                Projected Benefit Obligations, Fair Value of Plan                
                Assets, and Funded Status of Plan) (Details)                     
145: R130        Retirement Benefits (Schedule of Accumulated        HTML     65K  
                Benefit Obligations In Excess of and Less Than                   
                Fair Value of Plan Assets) (Details)                             
146: R131        Retirement Benefits (Schedule of Amounts            HTML     93K  
                Recognized in Balance Sheet and Other                            
                Comprehensive Income (Loss)) (Details)                           
147: R132        Retirement Benefits (Schedule of Changes in Plan    HTML     83K  
                Assets and Benefit Obligations Recorded in Other                 
                Comprehensive Income (Loss)) (Details)                           
148: R133        Retirement Benefits (Schedule of Expected Benefit   HTML     71K  
                Payments) (Details)                                              
149: R134        Retirement Benefits (Schedule of Allocation of      HTML     93K  
                Plan Assets, Actual and Target Allocations)                      
                (Details)                                                        
150: R135        Retirement Benefits (Schedule of Allocation of      HTML    113K  
                Plan Assets, Fair Value Hierarchy) (Details)                     
151: R136        Retirement Benefits (Schedule of Health Care Cost   HTML     55K  
                Trend Rates) (Details)                                           
152: R137        Stockholders' Equity (Dividends Declared and Paid)  HTML     51K  
                (Details)                                                        
153: R138        Stockholders' Equity (Narrative) (Details)          HTML    120K  
154: R139        Stockholders' Equity (Schedule of Assumptions Used  HTML     66K  
                in Estimate of Fair Value of Stock Option Awards)                
                (Details)                                                        
155: R140        Stockholders' Equity (Weighted Average Grant Date   HTML     51K  
                Fair Value of Options Granted) (Details)                         
156: R141        Stockholders' Equity (Summary of Activity for       HTML     73K  
                Stock Option Awards) (Details)                                   
157: R142        Stockholders' Equity (Changes in Non-vested Stock   HTML     66K  
                Options) (Details)                                               
158: R143        Stockholders' Equity (Stock Options Vested, or      HTML     80K  
                Expected to Vest and Exercisable) (Details)                      
159: R144        Stockholders' Equity (Other Stock Option            HTML     57K  
                Information) (Details)                                           
160: R145        Stockholders' Equity (Stock-based Compensation      HTML     49K  
                Expense Recognized) (Details)                                    
161: R146        Commitments and Contingencies (Future Minimum       HTML     60K  
                Unconditional Purchase Obligations) (Details)                    
162: R147        Commitments and Contingencies (Narrative)           HTML     50K  
                (Details)                                                        
163: R148        Segment Information (Narrative) (Details)           HTML     61K  
164: R149        Segment Information (Summary of Consolidated Net    HTML     72K  
                Sales and Earnings by Segment) (Details)                         
165: R150        Segment Information (Summary of Consolidated Total  HTML     76K  
                Assets, Depreciation and Amortization, and Capital               
                Expenditures by Segment) (Details)                               
166: R151        Segment Information (U.S. Government Related Sales  HTML     79K  
                by Segment) (Details)                                            
169: XML         IDEA XML File -- Filing Summary                      XML    357K  
167: XML         XBRL Instance -- wwd-10k_20220930_htm                XML  12.15M  
168: EXCEL       IDEA Workbook of Financial Reports                  XLSX    357K  
12: EX-101.CAL  XBRL Calculations -- wwd-20220930_cal                XML    409K 
13: EX-101.DEF  XBRL Definitions -- wwd-20220930_def                 XML   1.54M 
14: EX-101.LAB  XBRL Labels -- wwd-20220930_lab                      XML   2.77M 
15: EX-101.PRE  XBRL Presentations -- wwd-20220930_pre               XML   2.39M 
11: EX-101.SCH  XBRL Schema -- wwd-20220930                          XSD    417K 
170: JSON        XBRL Instance as JSON Data -- MetaLinks              808±  1.37M  
171: ZIP         XBRL Zipped Folder -- 0001564590-22-038033-xbrl      Zip   1.89M  


‘R29’   —   Stockholders’ Equity


This is an IDEA Financial Report.  [ Alternative Formats ]



 
 <>  v3.22.2.2
Stockholders' Equity
12 Months Ended
Equity [Abstract]  
Stockholders' Equity

Note 21.  Stockholders’ equity

Common Stock

Holders of Woodward’s common stock are entitled to receive dividends when and as declared by the Board and have the right to one vote per share on all matters requiring stockholder approval.

Dividends declared and paid were as follows:

 

 

 

Year Ended September 30,

 

 

 

2022

 

 

2021

 

 

2020

 

Dividends declared and paid

 

$

44,978

 

 

$

36,041

 

 

$

37,664

 

Dividend per share amount

 

 

0.7325

 

 

 

0.5688

 

 

 

0.6050

 

 

Stock repurchase program

In November 2019, the Board had authorized a program for the repurchase of up to $500,000 of Woodward’s outstanding shares of common stock on the open market or in privately negotiated transactions over a three-year period that was scheduled to expire in November 2022 (the “2019 Authorization”). During fiscal year 2022, we repurchased 233 shares of our common stock for $26,742 under the 2019 Authorization. During fiscal year 2021, we repurchased 404 shares of our common stock for $45,860 under the 2019 Authorization, of which 110 shares repurchased were in-transit for $12,516 as of September 30, 2021 and received in fiscal year 2022. During fiscal year 2020, we repurchased 124 shares of our common stock for $13,346 under the 2019 Authorization.

In January 2022, the Board terminated the 2019 Authorization and concurrently authorized a program for the repurchase of up to $800,000 of Woodward’s outstanding shares of common stock on the open market or in privately negotiated transactions over a two-year period ending in January 2024 (the “2022 Authorization”). During fiscal year 2022, we repurchased 3,890 shares of our common stock for $446,042 under the 2022 Authorization.

Stock-based compensation

Non-qualified stock option awards and restricted stock awards are granted to key management members and directors of the Company. The grant date for these awards is used for the measurement date. Vesting would be accelerated in the event of retirement, disability, or death of a participant, or change in control of the Company, as defined in the individual stock option agreements. These awards are valued as of the measurement date and are amortized on a straight-line basis over the requisite vesting period for all awards, including awards with graded vesting. Stock for exercised stock options and for restricted stock awards is issued from treasury stock shares.

Provisions governing outstanding stock option awards are included in the 2017 Omnibus Incentive Plan, as amended from time to time (the “2017 Plan”) and the 2006 Omnibus Incentive Plan (the “2006 Plan”), as applicable.    

The 2017 Plan was approved by Woodward’s stockholders in January 2017 and is a successor plan to the 2006 Plan.  As of September 14, 2016, the effective date of the 2017 Plan, the Board delegated authority to administer the 2017 Plan to the compensation committee of the board of directors (the “Committee”), including, but not limited to, the power to determine the recipients of awards and the terms of those awards. On January 29, 2020, Woodward’s stockholders approved an additional 1,000 shares of Woodward’s common stock to be made available for future grants. Under the 2017 Plan, there were approximately 2,938 shares of Woodward’s common stock available for future grants as of September 30, 2022.    

In connection with Thomas A. Gendron’s retirement, Charles (“Chip”) Blankenship, Jr. was appointed as Chief Executive Officer and President of the Company effective May 9, 2022. Mr. Blankenship received a one-time grant of restricted stock units ("RSUs") on his employment start date with a target delivered value of $3,400,000, all of which is scheduled to vest on the third anniversary of the grant date, generally subject to his continued employment. He also received a non-qualified stock option grant on his employment start date with a targeted delivered value of $2,200,000, the exercise price of which was equal to the closing price of the Company’s stock on the Nasdaq Stock Market on the date of grant and which is scheduled to vest over four years at a rate of 25% per year subject to his continued employment.

Stock options

Woodward believes that stock options align the interests of its employees and directors with the interests of its stockholders. Stock option awards are granted with an exercise price equal to the market price of Woodward’s stock at the date the grants are awarded, a ten-year term, and generally have a four-year vesting schedule at a rate of 25% per year.

The fair value of options granted is estimated as of the grant date using the Black-Scholes-Merton option-valuation model using the assumptions in the following table. Woodward calculates the expected term, which represents the average period of time that stock options granted are expected to be outstanding, based upon historical experience of plan participants. Expected volatility is based on historical volatility using daily stock price observations. The estimated dividend yield is based upon Woodward’s historical dividend practice and the market value of its common stock. The risk-free rate is based on the U.S. treasury yield curve, for periods within the contractual life of the stock option, at the time of grant.

 

 

 

Year Ended September 30,

 

 

 

2022

 

 

2021

 

 

2020

 

Weighted-average exercise price per share

 

$

115.30

 

 

$

82.46

 

 

$

90.52

 

Expected term (years)

 

 

 

6.6

 

-

 

8.7

 

 

 

 

6.5

 

-

 

8.7

 

 

 

 

6.4

 

-

 

8.7

 

Estimated volatility

 

 

 

33.8

%

-

 

36.4

%

 

 

 

33.3

%

-

 

36.2

%

 

 

 

25.7

%

-

 

35.1

%

Estimated dividend yield

 

 

 

0.6

%

-

 

0.8

%

 

 

 

0.3

%

-

 

0.6

%

 

 

 

0.4

%

-

 

0.9

%

Risk-free interest rate

 

 

 

1.1

%

-

 

3.5

%

 

 

 

0.4

%

-

 

1.0

%

 

 

 

0.4

%

-

 

1.7

%

 

The weighted average grant date fair value of options granted follows:

 

 

 

Year Ended September 30,

 

 

 

2022

 

 

2021

 

 

2020

 

Weighted-average grant date fair value of options

 

$

41.78

 

 

$

28.22

 

 

$

25.41

 

 

The following is a summary of the activity for stock option awards during the fiscal year ended September 30, 2022:

 

 

 

Number

 

 

Weighted-

Average Exercise

Price Per Share

 

Balance at September 30, 2021

 

 

5,339

 

 

$

68.21

 

Options granted

 

 

514

 

 

 

115.30

 

Options exercised

 

 

(468

)

 

 

47.23

 

Options forfeited

 

 

(44

)

 

 

88.65

 

Options expired

 

 

(2

)

 

 

93.79

 

Balance at September 30, 2022

 

 

5,339

 

 

 

74.40

 

 

Exercise prices of stock options outstanding as of September 30, 2022 range from $33.64 to $104.77.

Changes in non-vested stock options during the fiscal year ended September 30, 2022 were as follows:

 

 

 

Number

 

 

Weighted-

Average Grant

Date Fair Value

Per Share

 

Balance at September 30, 2021

 

 

2,063

 

 

$

25.77

 

Options granted

 

 

514

 

 

 

41.78

 

Options vested

 

 

(721

)

 

 

26.25

 

Options forfeited

 

 

(44

)

 

 

29.53

 

Balance at September 30, 2022

 

 

1,812

 

 

 

30.03

 

 

Information about stock options that have vested, or are expected to vest, and are exercisable at September 30, 2022 was as follows:

 

 

 

Number

 

 

Weighted-

Average

Exercise

Price

 

 

Weighted-

Average

Remaining

Life in Years

 

 

Aggregate

Intrinsic

Value

 

Options outstanding

 

 

5,339

 

 

$

74.40

 

 

 

5.6

 

 

$

64,895

 

Options vested and exercisable

 

 

3,528

 

 

 

65.83

 

 

 

4.4

 

 

 

58,726

 

Options vested and expected to vest

 

 

5,290

 

 

 

74.17

 

 

 

5.6

 

 

 

64,786

 

 

Other information follows:

 

 

 

Year Ended September 30,

 

 

 

2022

 

 

2021

 

 

2020

 

Total fair value of stock options vested

 

$

18,945

 

 

$

19,324

 

 

$

17,423

 

Total intrinsic value of options exercised

 

32,709

 

 

 

63,667

 

 

 

50,059

 

Cash received from exercises of stock options

 

21,897

 

 

 

34,748

 

 

 

24,969

 

Excess tax benefit realized from exercise of stock options

 

6,472

 

 

 

12,364

 

 

 

9,399

 

 

Restricted Stock

During fiscal year 2022, Woodward granted 54 restricted stock units (“RSUs”) under its long-term incentive program as part of recent recruiting activities. The RSUs granted under this program have a weighted average grant date fair value of $99.15 per unit and are generally scheduled to vest on the third or fourth anniversary of the respective grant dates, generally subject to recipients’ continued employment.

Stock-based compensation expense

Woodward recognizes stock-based compensation expense on a straight-line basis over the requisite service period.  Pursuant to the form stock option agreements used by the Company, with terms approved by the administrator of the applicable plan, the requisite service period can be less than the four-year vesting period based on grantee’s retirement eligibility. As such, the recognition of stock-based compensation expense associated with some stock option grants can be accelerated to a period of less than four years, including immediate recognition of stock-based compensation expense on the date of grant.

Stock-based compensation expense recognized was as follows:

 

 

 

Year Ended September 30,

 

 

 

2022

 

 

2021

 

 

2020

 

Employee stock-based compensation expense

 

$

20,109

 

 

$

21,475

 

 

$

22,903

 

At September 30, 2022, there was approximately $16,261 of total unrecognized compensation expense related to non-vested stock-based compensation arrangements, including both stock options and restricted stock awards. The pre-vesting forfeiture rates for purposes of determining stock-based compensation expense recognized were estimated to be 0% for members of Woodward’s board of directors and 7.3% for all others. The remaining unrecognized compensation cost is expected to be recognized over a weighted-average period of approximately 1.8 years.


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:11/18/22
For Period end:9/30/22
5/9/223,  4
9/30/2110-K
1/29/208-K,  DEF 14A
9/14/168-K
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/17/23  Woodward, Inc.                    10-K        9/30/23  171:36M                                    Donnelley … Solutions/FA
 2/15/23  Woodward, Inc.                    S-8         2/15/23    4:267K                                   Donnelley … Solutions/FA


21 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/06/22  Woodward, Inc.                    10-Q        3/31/22  122:19M                                    ActiveDisclosure/FA
 2/04/22  Woodward, Inc.                    10-Q       12/31/21  120:17M                                    ActiveDisclosure/FA
11/19/21  Woodward, Inc.                    10-K        9/30/21  166:36M                                    ActiveDisclosure/FA
 4/06/20  Woodward, Inc.                    8-K:1,3,5,7 4/03/20   15:742K                                   Donnelley … Solutions/FA
 5/08/19  Woodward, Inc.                    10-Q        3/31/19  129:21M
11/13/18  Woodward, Inc.                    10-K        9/30/18  159:30M
 8/08/18  Woodward, Inc.                    10-Q        6/30/18  115:21M
 6/04/18  Woodward, Inc.                    8-K:1,2,7,9 5/31/18    6:839K                                   Donnelley … Solutions/FA
 1/25/17  Woodward, Inc.                    10-Q       12/31/16   99:10M
11/16/16  Woodward, Inc.                    10-K        9/30/16  150:30M
 2/09/16  Woodward, Inc.                    10-Q       12/31/15  101:11M
 1/08/16  Woodward, Inc.                    8-K:1,2,9   1/08/16    4:1.6M
11/12/14  Woodward, Inc.                    10-K        9/30/14  149:39M
11/14/13  Woodward, Inc.                    10-K        9/30/13  154:37M
10/04/13  Woodward, Inc.                    8-K:1,2,5,8 9/30/13    5:838K                                   Donnelley … Solutions/FA
11/15/12  Woodward, Inc.                    10-K        9/30/12  153:19M                                    Donnelley … Solutions/FA
11/16/11  Woodward, Inc.                    10-K        9/30/11  153:13M                                    Donnelley … Solutions/FA
 1/28/11  Woodward, Inc.                    8-K:5,7     1/26/11    4:116K                                   Donnelley Fi… Express/FA
11/20/08  Woodward, Inc.                    10-K        9/30/08   13:1.5M                                   RR Donnelley
 4/28/06  Woodward, Inc.                    S-8         4/28/06    5:201K                                   Bowne Boc/FA
12/22/00  Woodward, Inc.                    10-K®       9/30/00   23:997K
Top
Filing Submission 0001564590-22-038033   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 4:14:11.2pm ET